The overall objective of the Neuropathology Core of the University of Kentucky Alzheimer's Disease Center is to support research on normal brain aging, presymptomatic Alzheimer's disease (AD), mild cognitive impairment (MCI), early and late AD, mixed dementia syndromes, and other dementing disorders. The core will perform short postmortem interval (2-4 hr) autopsies by our Rapid Autopsy Team on longitudinally followed subjects from our normal control BRAiNS Clinic, Dementia Research Clinic, and Kentucky Clinic North Minority Satellite (KYCN), and provide brain specimens, CSF and synaptosomes for investigators at UK, other ADCs, and outside investigators. The core will also provide consensus conference determined diagnoses, quantitation of neurofibrillary tangles (NFT), neuritic plaques, and diffuse plaques from 8 brain regions, Abeta 1-40 and 1-42 quantitation, Braak staging, CERAD, and NIA-Reagan Institute staging on all autopsied cases to investigators. The core will maintain a tissue bank of the above specimens and frozen serum, plasma, buffy coats and CSF from living patients from the Dementia Research Clinic, the normal control BRAiNS Clinic, and KYCN. Special emphasis will be placed on defining the neuropathological findings in the brains of the oldest old (>85), and providing investigators with specimens from cognitively normal control subjects with no Abeta and few NFT (Braak O-ll) (successful cerebral aging) and cognitively normal control subjects with abundant Abeta and NFT. Monthly or more frequent consensus conferences will be held with the Clinical Core to define clinical-pathological diagnoses on all autopsied subjects. Clinical-pathological conferences will be held every two months and twice annually for the Ohio Valley Geriatric Research Center. Support for the Nun Study, the Honolulu Asian Aging study, the UK Udall Parkinson's Disease Research Center and the Georgia Centenarian Study will be provided by the Neuropathology Core. This core's unique opportunity to conduct clinical-pathological correlative studies on longitudinally followed subjects to better understand normal brain aging and the transition to dementia and the factors involved in this transition, could contribute to early interventions and possible preventive measures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG028383-04
Application #
7898788
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
4
Fiscal Year
2009
Total Cost
$251,509
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Lanzillotta, Chiara; Tramutola, Antonella; Meier, Shelby et al. (2018) Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models. J Alzheimers Dis 62:347-359
Nelson, Peter T; Abner, Erin L; Patel, Ela et al. (2018) The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases. J Neuropathol Exp Neurol 77:2-20
Goetzl, Edward J; Abner, Erin L; Jicha, Gregory A et al. (2018) Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J 32:888-893
Gal, Jozsef; Chen, Jing; Katsumata, Yuriko et al. (2018) Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. J Neuropathol Exp Neurol 77:21-39
Goetzl, Edward J; Schwartz, Janice B; Abner, Erin L et al. (2018) High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol 83:544-552
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827

Showing the most recent 10 out of 471 publications